Concepts in crotaline snake envenomation management

Orthopedics

Volumn 29, Issue 12, 2006, Pages 1083-1087

  Cox, Mark R ^a   Reeves, Jordan K ^b   Smith, Kelly M ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIVENIN; CROFAB; FABAV; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG; VENOM ANTISERUM;

ANAPHYLAXIS; ARTHRALGIA; ARTICLE; BLOOD CLOTTING DISORDER; BRONCHOSPASM; CLINICAL TRIAL; CRYOTHERAPY; DEBRIDEMENT; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; ELECTROCONVULSIVE THERAPY; ENVENOMATION; EPIDEMIOLOGICAL DATA; FASCIOTOMY; HEMATURIA; HUMAN; HYPOTENSION; NONHUMAN; SERUM SICKNESS; SKIN MANIFESTATION; SNAKEBITE; URTICARIA;

EID: 33846408322     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20061201-07     Document Type: Article

References (15)

1. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002; 347:347-356.
2. Seiler JG III, Sagerman SD, Geller RJ, Eldridge JC, Fleming LL. Venomous snake bite: current concepts of treatment. Orthopedics. 1994; 17:707-714.
3. Jucket G, Hancox JG. Venomous snakebites in the united states: management review and update. American Family Physician [serial online]. 2002; 65:1367-1374. Available at: http://www.aafp.org/afp/20020401/1367. pdf#search=%22incidence%20of%20snakebites%20in%20the%20United% 20States%22. Accessed September 27, 2006.
4. Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001; 37:181-188.
5. Bigony ML. Snakebit! Texas Parks & Wildlife Magazine [archived on the Internet]. 1995 March [cited 2006 Sept 27]. Available from: http://www.tpwd.state.tx.us/learning/junior_naturalists/snakebit.phtml.
6. Erk D. Rattlesnake bites: old-time treatments can be worse than bites. Physicians Practice [serial online]. 2005. Available at: http://www.wmcnet.org/workfiles/media/Erk_JA05.pdf. Accessed September 27, 2006.
7. Hall EL. Role of surgical intervention in the management of crotaline snake envenomation. Ann Emerg Med. 2001; 37:175-180.
8. Gold BS, Barish RA, Dart RC. North American snake envenomation: diagnosis, treatment and management. Emerg Med Clin N Am. 2004; 22:423-443.
9. McKinney PE. Out-of-hospital and interhospital management of crotaline snakebite. Ann Emerg Med. 2001; 37:168-174.
10. Dart RC, Hurlburt KM, Garcia R, Boren J. Validation of a severity score for the assessment of crotalid snake bite. Ann Emerg Med. 1996; 27:321-326.
11. Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom Ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997; 30:33-39.
12. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations, part II: guidelines for clinical management with crotalin fab antivenom. Ann Emerg Med. 2001; 37:196-201.
13. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001; 161:2030-2036.
14. Protherics Inc. Crotalidae polyvalent immune fab (ovine) [CroFab] package insert. Brentwood, Tenn: 2002.
15. Seifert SA, Boyer LV. Recurrence phenomena after immunoglobulin therapy for snake envenomations, part I: Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med. 2001; 37:189-195.